83 FR 32906 - Importer of Controlled Substances Application: Cerilliant Corporation
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 136 (July 16, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 136 (July 16, 2018)
| Page Range | 32906-32908 | |
| FR Document | 2018-15139 |
[Federal Register Volume 83, Number 136 (Monday, July 16, 2018)] [Notices] [Pages 32906-32908] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-15139] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Cerilliant Corporation ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 15, 2018. Such persons may also file a written request for a hearing on the application on or before August 15, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 12, 2018, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC). 1233 I Cathinone.......................... 1235 I Methcathinone...................... 1237 I 4-Fluoro-N-methylcathinone (4-FMC). 1238 I Pentedrone ([alpha]- 1246 I methylaminovalerophenone). Mephedrone (4-Methyl-N- 1248 I methylcathinone). 4-Methyl-N-ethylcathinone (4-MEC).. 1249 I Naphyrone.......................... 1258 I N-Ethylamphetamine................. 1475 I N,N-Dimethylamphetamine............ 1480 I Fenethylline....................... 1503 I Methaqualone....................... 2565 I JWH-250 (1-Pentyl-3-(2- 6250 I methoxyphenylacetyl) indole). SR-18 (Also known as RCS-8) (1- 7008 I Cyclohexylethyl-3-(2- methoxyphenylacetyl) indole). 5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I Fluoropentyl)1H-indol-3- yl](2,2,3,3- tetramethylcyclopropyl)methanone. AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I oxobutan-2-yl)-1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide). JWH-019 (1-Hexyl-3-(1- 7019 I naphthoyl)indole). AB-PINACA (N-(1-amino-3-methyl-1- 7023 I oxobutan-2-yl)-1-pentyl-1H- indazole-3-carboxamide). THJ-2201 [1-(5-fluoropentyl)-1H- 7024 I indazol-3-yl](naphthalen-1- yl)methanone. AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3- carboxamide. ADB-PINACA (N-(1-amino-3,3-dimethyl- 7035 I 1-oxobutan-2-yl)-1-pentyl-1H- indazole-3-carboxamide). APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I pentyl-1H-indazole-3-carboxamide. JWH-081 (1-Pentyl-3-(1-(4- 7081 I methoxynaphthoyl) indole). SR-19 (Also known as RCS-4) (1- 7104 I Pentyl-3-[(4-methoxy)-benzoyl] indole. JWH-018 (also known as AM678) (1- 7118 I Pentyl-3-(1-naphthoyl)indole). JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I naphthoyl) indole). UR-144 (1-Pentyl-1H-indol-3- 7144 I yl)(2,2,3,3- tetramethylcyclopropyl)methanone. JWH-073 (1-Butyl-3-(1- 7173 I naphthoyl)indole). JWH-200 (1-[2-(4-Morpholinyl)ethyl]- 7200 I 3-(1-naphthoyl)indole). AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I naphthoyl) indole). JWH-203 (1-Pentyl-3-(2- 7203 I chlorophenylacetyl) indole). PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I indole-3-carboxylate). 5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I fluoropentyl)-1H-indole-3- carboxylate). Alpha-ethyltryptamine.............. 7249 I Ibogaine........................... 7260 I CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I [(1R,3S)-3-hydroxycyclohexyl- phenol). CP-47,497 C8 Homologue (5-(1,1- 7298 I Dimethyloctyl)-2-[(1R,3S)3- hydroxycyclohexyl-phenol). [[Page 32907]] Lysergic acid diethylamide......... 7315 I 2,5-Dimethoxy-4-(n)- 7348 I propylthiophenethylamine (2C-T-7). Marihuana.......................... 7360 I Parahexyl.......................... 7374 I Mescaline.......................... 7381 I 2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I ethanamine (2C-T-2). 3,4,5-Trimethoxyamphetamine........ 7390 I 4-Bromo-2,5-dimethoxyamphetamine... 7391 I 4-Bromo-2,5-dimethoxyphenethylamine 7392 I 4-Methyl-2,5-dimethoxyamphetamine.. 7395 I 2,5-Dimethoxyamphetamine........... 7396 I JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I naphthoyl) indole). 3,4-Methylenedioxyamphetamine...... 7400 I 5-Methoxy-3,4- 7401 I methylenedioxyamphetamine. N-Hydroxy-3,4- 7402 I methylenedioxyamphetamine. 3,4-Methylenedioxy-N- 7404 I ethylamphetamine. 3,4-Methylenedioxymethamphetamine.. 7405 I 4-Methoxyamphetamine............... 7411 I 5-Methoxy-N-N-dimethyltryptamine... 7431 I Alpha-methyltryptamine............. 7432 I Bufotenine......................... 7433 I Diethyltryptamine.................. 7434 I Dimethyltryptamine................. 7435 I Psilocybin......................... 7437 I Psilocyn........................... 7438 I 5-Methoxy-N,N-diisopropyltryptamine 7439 I N-Ethyl-1-phenylcyclohexylamine.... 7455 I 1-(1-Phenylcyclohexyl)pyrrolidine.. 7458 I 1-[1-(2- 7470 I Thienyl)cyclohexyl]piperidine. N-Benzylpiperazine................. 7493 I 4-Methyl- 7498 I alphapyrrolidinopropiophenone (4- MePPP). 2-(2,5-Dimethoxy-4-methylphenyl) 7508 I ethanamine (2C-D). 2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I ethanamine (2C-E). 2-(2,5-Dimethoxyphenyl) ethanamine 7517 I (2C-H). 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I ethanamine (2C-I). 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I ethanamine (2C-C). 2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I ethanamine (2C-N). 2-(2,5-Dimethoxy-4-(n)- 7524 I propylphenyl) ethanamine (2C-P). 2-(4-Isopropylthio)-2,5- 7532 I dimethoxyphenyl) ethanamine (2C-T- 4). MDPV (3,4- 7535 I Methylenedioxypyrovalerone). 2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I (2-methoxybenzyl) ethanamine (25B- NBOMe). 2-(4-chloro-2,5-dimethoxyphenyl)-N- 7537 I (2-methoxybenzyl) ethanamine (25C- NBOMe). 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I methoxybenzyl) ethanamine (25I- NBOMe). Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone). Butylone........................... 7541 I Pentylone.......................... 7542 I alpha-pyrrolidinopentiophenone 7545 I ([alpha]-PVP). alpha-pyrrolidinobutiophenone 7546 I ([alpha]-PBP). AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I iodobenzoyl) indole). Desomorphine....................... 9055 I Etorphine (except HCl)............. 9056 I Codeine methylbromide.............. 9070 I Heroin............................. 9200 I Morphine-N-oxide................... 9307 I Normorphine........................ 9313 I Pholcodine......................... 9314 I U-47700 (3,4-dichloro-N-[2- 9547 I (dimethylamino)cyclohexyl]-N- methylbenzamide). AH-7921 (3,4-dichloro-N-[(1- 9551 I dimethylamino)cyclohexylmethyl]ben zamide)). Acetylmethadol..................... 9601 I Allylprodine....................... 9602 I Alphacetylmethadol except levo- 9603 I alphacetylmethadol. Alphameprodine..................... 9604 I Alphamethadol...................... 9605 I Betacetylmethadol.................. 9607 I Betameprodine...................... 9608 I Betamethadol....................... 9609 I Betaprodine........................ 9611 I Dextromoramide..................... 9613 I Dipipanone......................... 9622 I Hydroxypethidine................... 9627 I Noracymethadol..................... 9633 I Norlevorphanol..................... 9634 I Normethadone....................... 9635 I Racemoramide....................... 9645 I [[Page 32908]] Trimeperidine...................... 9646 I 1-Methyl-4-phenyl-4- 9661 I propionoxypiperidine. Tilidine........................... 9750 I Para-Fluorofentanyl................ 9812 I 3-Methylfentanyl................... 9813 I Alpha-methylfentanyl............... 9814 I Acetyl-alpha-methylfentanyl........ 9815 I Beta-hydroxyfentanyl............... 9830 I Beta-hydroxy-3-methylfentanyl...... 9831 I Alpha-methylthiofentanyl........... 9832 I 3-Methylthiofentanyl............... 9833 I Thiofentanyl....................... 9835 I Methamphetamine.................... 1105 II Methylphenidate.................... 1724 II Amobarbital........................ 2125 II Pentobarbital...................... 2270 II Secobarbital....................... 2315 II Glutethimide....................... 2550 II Nabilone........................... 7379 II 1-Phenylcyclohexylamine............ 7460 II Phencyclidine...................... 7471 II Phenylacetone...................... 8501 II 1-Piperidinocyclohexanecarbonitrile 8603 II Alphaprodine....................... 9010 II Dihydrocodeine..................... 9120 II Ecgonine........................... 9180 II Ethylmorphine...................... 9190 II Levomethorphan..................... 9210 II Levorphanol........................ 9220 II Meperidine......................... 9230 II Dextropropoxyphene, bulk (non- 9273 II dosage forms). Levo-alphacetylmethadol............ 9648 II Noroxymorphone..................... 9668 II Racemethorphan..................... 9732 II Alfentanil......................... 9737 II Remifentanil....................... 9739 II Sufentanil......................... 9740 II Carfentanil........................ 9743 II Tapentadol......................... 9780 II ------------------------------------------------------------------------ The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards and distribution to their research and forensic customers. Dated: July 10, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-15139 Filed 7-13-18; 8:45 am] BILLING CODE 4410-09-P
![32906 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices
Controlled DEPARTMENT OF JUSTICE Drive, Springfield, Virginia 22152; and
Drug code Schedule
substance (2) Drug Enforcement Administration,
Drug Enforcement Administration Attn: DEA Federal Register
Methylphenidate ..... 1724 II Representative/DRW, 8701 Morrissette
Amobarbital ............ 2125 II [Docket No. DEA–392]
Drive, Springfield, Virginia 22152.
Pentobarbital .......... 2270 II
Importer of Controlled Substances SUPPLEMENTARY INFORMATION: The
Secobarbital ............ 2315 II
Codeine .................. 9050 II Application: Cerilliant Corporation Attorney General has delegated his
Oxycodone ............. 9143 II
authority under the Controlled
ACTION: Notice of application. Substances Act to the Administrator of
Hydromorphone ...... 9150 II
Hydrocodone .......... 9193 II the Drug Enforcement Administration
DATES: Registered bulk manufacturers of (DEA), 28 CFR 0.100(b). Authority to
Methadone .............. 9250 II
the affected basic classes, and exercise all necessary functions with
Methadone inter- 9254 II
mediate.
applicants therefore, may file written respect to the promulgation and
Morphine ................. 9300 II comments on or objections to the implementation of 21 CFR part 1301,
Oripavine ................ 9330 II issuance of the proposed registration on incident to the registration of
Thebaine ................. 9333 II or before August 15, 2018. Such persons manufacturers, distributors, dispensers,
Opium tincture ........ 9630 II may also file a written request for a importers, and exporters of controlled
Oxymorphone ......... 9652 II hearing on the application on or before substances (other than final orders in
August 15, 2018. connection with suspension, denial, or
The company plans to manufacture ADDRESSES: Written comments should revocation of registration) has been
the listed controlled substances in bulk be sent to: Drug Enforcement delegated to the Assistant Administrator
Administration, Attention: DEA Federal of the DEA Diversion Control Division
for sale to its customers.
Register Representative/DRW, 8701 (‘‘Assistant Administrator’’) pursuant to
Dated: July 10, 2018. Morrissette Drive, Springfield, Virginia section 7 of 28 CFR part 0, appendix to
John J. Martin, 22152. All requests for hearing must be subpart R.
Assistant Administrator. sent to: Drug Enforcement In accordance with 21 CFR
[FR Doc. 2018–15138 Filed 7–13–18; 8:45 am] Administration, Attn: Administrator, 1301.34(a), this is notice that on June
8701 Morrissette Drive, Springfield, 12, 2018, Cerilliant Corporation, 811
BILLING CODE 4410–09–P
Virginia 22152. All request for hearing Paloma Drive, Suite A, Round Rock,
should also be sent to: (1) Drug Texas 78665 applied to be registered as
Enforcement Administration, Attn: an importer of the following basic
Hearing Clerk/LJ, 8701 Morrissette classes of controlled substances:
Controlled substance Drug code Schedule
3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. 1233 I
Cathinone ........................................................................................................................................................................ 1235 I
Methcathinone ................................................................................................................................................................. 1237 I
4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. 1238 I
Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... 1249 I
Naphyrone ....................................................................................................................................................................... 1258 I
N-Ethylamphetamine ....................................................................................................................................................... 1475 I
N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I
Fenethylline ..................................................................................................................................................................... 1503 I
Methaqualone .................................................................................................................................................................. 2565 I
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. 6250 I
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ 7008 I
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoropentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................. 7011 I
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................... 7024 I
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................. 7031 I
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 7081 I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .................................................................... 7104 I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... 7122 I
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. 7144 I
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7173 I
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... 7200 I
sradovich on DSK3GMQ082PROD with NOTICES
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 7222 I
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 7225 I
Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I
Ibogaine ........................................................................................................................................................................... 7260 I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... 7298 I
VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1](https://thefederalregister.org/doc/83_FR_33042/page/1.svg)
![Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 32907
Controlled substance Drug code Schedule
Lysergic acid diethylamide .............................................................................................................................................. 7315 I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .............................................................................................. 7348 I
Marihuana ........................................................................................................................................................................ 7360 I
Parahexyl ......................................................................................................................................................................... 7374 I
Mescaline ......................................................................................................................................................................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) ........................................................................................... 7385 I
3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I
4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I
2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I
3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I
3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I
4-Methoxyamphetamine .................................................................................................................................................. 7411 I
5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ 7431 I
Alpha-methyltryptamine ................................................................................................................................................... 7432 I
Bufotenine ........................................................................................................................................................................ 7433 I
Diethyltryptamine ............................................................................................................................................................. 7434 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
Psilocybin ......................................................................................................................................................................... 7437 I
Psilocyn ........................................................................................................................................................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I
N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I
N-Benzylpiperazine .......................................................................................................................................................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 7498 I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .................................................................................................. 7508 I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E) ..................................................................................................... 7509 I
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ................................................................................................................. 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................ 7518 I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .................................................................................................. 7519 I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) .................................................................................................... 7521 I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ............................................................................................. 7524 I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) .................................................................................... 7532 I
MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) .................................................... 7536 I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) .................................................... 7537 I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ......................................................... 7538 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I
Butylone ........................................................................................................................................................................... 7541 I
Pentylone ......................................................................................................................................................................... 7542 I
alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I
alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... 7694 I
Desomorphine ................................................................................................................................................................. 9055 I
Etorphine (except HCl) .................................................................................................................................................... 9056 I
Codeine methylbromide ................................................................................................................................................... 9070 I
Heroin .............................................................................................................................................................................. 9200 I
Morphine-N-oxide ............................................................................................................................................................ 9307 I
Normorphine .................................................................................................................................................................... 9313 I
Pholcodine ....................................................................................................................................................................... 9314 I
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. 9547 I
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I
Acetylmethadol ................................................................................................................................................................ 9601 I
Allylprodine ...................................................................................................................................................................... 9602 I
Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I
Alphameprodine ............................................................................................................................................................... 9604 I
Alphamethadol ................................................................................................................................................................. 9605 I
Betacetylmethadol ........................................................................................................................................................... 9607 I
Betameprodine ................................................................................................................................................................ 9608 I
Betamethadol ................................................................................................................................................................... 9609 I
sradovich on DSK3GMQ082PROD with NOTICES
Betaprodine ..................................................................................................................................................................... 9611 I
Dextromoramide .............................................................................................................................................................. 9613 I
Dipipanone ....................................................................................................................................................................... 9622 I
Hydroxypethidine ............................................................................................................................................................. 9627 I
Noracymethadol ............................................................................................................................................................... 9633 I
Norlevorphanol ................................................................................................................................................................ 9634 I
Normethadone ................................................................................................................................................................. 9635 I
Racemoramide ................................................................................................................................................................ 9645 I
VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1](https://thefederalregister.org/doc/83_FR_33042/page/2.svg)
![32908 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices
Controlled substance Drug code Schedule
Trimeperidine ................................................................................................................................................................... 9646 I
1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 9661 I
Tilidine ............................................................................................................................................................................. 9750 I
Para-Fluorofentanyl ......................................................................................................................................................... 9812 I
3-Methylfentanyl .............................................................................................................................................................. 9813 I
Alpha-methylfentanyl ....................................................................................................................................................... 9814 I
Acetyl-alpha-methylfentanyl ............................................................................................................................................. 9815 I
Beta-hydroxyfentanyl ....................................................................................................................................................... 9830 I
Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ 9831 I
Alpha-methylthiofentanyl ................................................................................................................................................. 9832 I
3-Methylthiofentanyl ......................................................................................................................................................... 9833 I
Thiofentanyl ..................................................................................................................................................................... 9835 I
Methamphetamine ........................................................................................................................................................... 1105 II
Methylphenidate .............................................................................................................................................................. 1724 II
Amobarbital ...................................................................................................................................................................... 2125 II
Pentobarbital .................................................................................................................................................................... 2270 II
Secobarbital ..................................................................................................................................................................... 2315 II
Glutethimide ..................................................................................................................................................................... 2550 II
Nabilone ........................................................................................................................................................................... 7379 II
1-Phenylcyclohexylamine ................................................................................................................................................ 7460 II
Phencyclidine ................................................................................................................................................................... 7471 II
Phenylacetone ................................................................................................................................................................. 8501 II
1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ 8603 II
Alphaprodine .................................................................................................................................................................... 9010 II
Dihydrocodeine ................................................................................................................................................................ 9120 II
Ecgonine .......................................................................................................................................................................... 9180 II
Ethylmorphine .................................................................................................................................................................. 9190 II
Levomethorphan .............................................................................................................................................................. 9210 II
Levorphanol ..................................................................................................................................................................... 9220 II
Meperidine ....................................................................................................................................................................... 9230 II
Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II
Levo-alphacetylmethadol ................................................................................................................................................. 9648 II
Noroxymorphone ............................................................................................................................................................. 9668 II
Racemethorphan ............................................................................................................................................................. 9732 II
Alfentanil .......................................................................................................................................................................... 9737 II
Remifentanil ..................................................................................................................................................................... 9739 II
Sufentanil ......................................................................................................................................................................... 9740 II
Carfentanil ....................................................................................................................................................................... 9743 II
Tapentadol ....................................................................................................................................................................... 9780 II
The company plans to import small SUMMARY: The Department of Justice are encouraged. Your comments should
quantities of the listed controlled (DOJ), Office of Justice Programs, address one or more of the following
substances for the manufacture of Bureau of Justice Statistics, will be four points:
analytical reference standards and submitting the following information
distribution to their research and collection request to the Office of —Evaluate whether the proposed
forensic customers. Management and Budget (OMB) for collection of information is necessary
review and approval in accordance with for the proper performance of the
Dated: July 10, 2018. functions of the Bureau of Justice
the Paperwork Reduction Act of 1995.
John J. Martin, Statistics, including whether the
DATES: Comments are encouraged and
Assistant Administrator. information will have practical utility;
will be accepted for 60 days until
[FR Doc. 2018–15139 Filed 7–13–18; 8:45 am] —Evaluate the accuracy of the agency’s
September 14, 2018.
BILLING CODE 4410–09–P estimate of the burden of the
FOR FURTHER INFORMATION CONTACT: If
proposed collection of information,
you have additional comments
including the validity of the
DEPARTMENT OF JUSTICE especially on the estimated public
methodology and assumptions used;
burden or associated response time,
suggestions, or need a copy of the —Evaluate whether and if so how the
[OMB Number 1121–NEW]
proposed information collection quality, utility, and clarity of the
Agency Information Collection instrument with instructions or information to be collected can be
Activities; Proposed eCollection additional information, please contact enhanced; and
eComments Requested; Approval of a Barbara Oudekerk, Statistician, Bureau —Minimize the burden of the collection
New Collection; Comments Requested: of Justice Statistics, 810 Seventh Street of information on those who are to
sradovich on DSK3GMQ082PROD with NOTICES
National Survey of Victim Service NW, Washington, DC 20531 (email: respond, including through the use of
Providers (NCVSP) Barbara.a.oudekerk@usdoj.gov; appropriate automated, electronic,
telephone: 202–616–3904). mechanical, or other technological
AGENCY:Bureau of Justice Statistics, SUPPLEMENTARY INFORMATION: Written collection techniques or other forms
Department of Justice. comments and suggestions from the of information technology, e.g.,
public and affected agencies concerning permitting electronic submission of
ACTION: 60-day notice.
the proposed collection of information responses.
VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1](https://thefederalregister.org/doc/83_FR_33042/page/3.svg)
Document Created: 2018-07-14 00:53:44
Document Modified: 2018-07-14 00:53:44
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 15, 2018. Such persons may also file a written request for a hearing on the application on or before August 15, 2018. | |
| FR Citation | 83 FR 32906 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR